Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical Research in Cardiology
Literature
1.
Ibanez B, James S, Agewall S et al (2018) 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 39:119–177CrossRefPubMed
2.
Halkin A, Singh M, Nikolsky E et al (2005) Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J Am Coll Cardiol 45:1397–1405CrossRefPubMed
3.
De Luca G, Suryapranata H, van't Hof AW et al (2004) Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early discharge. Circulation 109:2737–2743CrossRefPubMed
4.
5.
6.
7.
Kammler J, Kypta A, Hofmann R et al (2009) TIMI 3 flow after primary angioplasty is an important predictor for outcome in patients with acute myocardial infarction. Clin Res Cardiol 98(3):165–170CrossRefPubMed
8.
Zahler D, Lee-Rozenfeld K, Ravid D et al (2019) Relation of lowering door-to-balloon time and mortality in ST segment elevation myocardial infarction patients undergoing percutaneous coronary intervention. Clin Res Cardiol 108(9):1053–1058CrossRefPubMed
Metadata
Title
Identifying very low-risk STEMI patients for early ICU discharge in the COVID-19 era
Authors
Omar Abdul-Jawad Altisent
Xavier Carrillo
Rishi Puri
Antoni Bayés-Genís
Publication date
01-12-2020
Publisher
Springer Berlin Heidelberg
Published in
Clinical Research in Cardiology / Issue 12/2020
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-020-01702-0

Other articles of this Issue 12/2020

Clinical Research in Cardiology 12/2020 Go to the issue

Review

Coronavirus Disease 2019 (COVID-19) and its implications for cardiovascular care: expert document from the German Cardiac Society and the World Heart Federation

Letter to the Editors

COVID-19 sends STEMI to quarantine!?

Original Paper

Off-the-shelf barrier for emergency intubation in the cardiac catheterization laboratory during the coronavirus disease 2019 (COVID-19) pandemic

Original Paper

31 days of COVID-19—cardiac events during restriction of public life—a comparative study

Original Paper

Effects of surgical and FFP2/N95 face masks on cardiopulmonary exercise capacity

Original Paper

Decline of emergency admissions for cardiovascular and cerebrovascular events after the outbreak of COVID-19

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits